TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
1.150
+0.010 (0.88%)
At close: Dec 5, 2025, 4:00 PM EST
1.170
+0.020 (1.74%)
After-hours: Dec 5, 2025, 6:40 PM EST

Company Description

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy.

The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs.

It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

TELA Bio, Inc.
TELA Bio logo
Country United States
Founded 2012
IPO Date Nov 8, 2019
Industry Medical Devices
Sector Healthcare
Employees 209
CEO Antony Koblish

Contact Details

Address:
1 Great Valley Parkway, Suite 24
Malvern, Pennsylvania 19355
United States
Phone 484 320 2930
Website telabio.com

Stock Details

Ticker Symbol TELA
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $13.00
CIK Code 0001561921
CUSIP Number 872381108
ISIN Number US8723811084
Employer ID 45-5320061
SIC Code 3841

Key Executives

Name Position
Antony Koblish Co-founder, Chief Executive Officer and Director
Jeffrey Blizard President of TELA Bio and Director
Roberto E. Cuca J.D. Chief Financial Officer and Chief Operating Officer
Paul Talmo Chief Technology Officer
Megan Smeykal Vice President, Corporate Controller, Chief Accounting Officer and Principal Accounting Officer
D. Taylor Ocasio General Counsel and Corporate Secretary
Jim Hagen Senior Vice President of Strategic Commercial Operations and Marketing
Jennifer Lou Armstrong Senior Vice President of Human Resources
Gregory A. Firestone Chief Commercial Officer
Michael Leonard Senior Vice President of Technical Operations

Latest SEC Filings

Date Type Title
Nov 17, 2025 SCHEDULE 13G/A Filing
Nov 14, 2025 8-K Current Report
Nov 14, 2025 424B5 Filing
Nov 14, 2025 10-Q Quarterly Report
Nov 14, 2025 SCHEDULE 13G/A Filing
Nov 13, 2025 424B5 Filing
Nov 13, 2025 8-K Current Report
Nov 3, 2025 8-K Current Report
Oct 15, 2025 SCHEDULE 13G/A Filing
Oct 9, 2025 8-K Current Report